A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study of Mitapivat in Patients with Sickle Cell Disease: RISE UP Phase 2 Results

被引:2
|
作者
Idowu, Modupe [1 ]
Otieno, Lucas [2 ]
Dumitriu, Bogdan [3 ]
Lobo, Clarisse L. C. [4 ]
Thein, Swee Lay [5 ]
Andemariam, Biree [6 ]
Nnodu, Obiageli E. [7 ]
Inati, Adlette [8 ]
Glaros, Alexander K. [9 ]
Olalla Saad, Sara Teresinha [10 ,11 ]
Bartolucci, Pablo [12 ]
Colombatti, Raffaella [13 ]
Taher, Ali T. [14 ]
Abboud, Miguel R. [15 ]
Oluyadi, Abdulafeez [16 ]
Iyer, Varsha [16 ]
Yin, Ophelia [17 ,18 ]
Morris, Susan [16 ]
Yates, Amber M. [16 ]
Shao, Hui [16 ]
Patil, Spurthi [16 ]
Urbstonaitis, Rolandas [16 ]
Zaidi, Ahmar U. [16 ]
Smith, Wally R. [19 ]
机构
[1] UTHealth, McGovern Med Sch, Houston, TX USA
[2] Victoria Biomed Res Inst, Kisumu, Kenya
[3] Mid Atlantic Permanente Med Grp, Largo, MD USA
[4] HEMORIO, Div Res, Rio De Janeiro, Brazil
[5] NHLBI, Sickle Cell Branch, Bethesda, MD USA
[6] Univ Connecticut Hlth, New England Sickle Cell Inst, Farmington, CT USA
[7] Univ Abuja, Dept Haematol & Blood Transfus, Coll Hlth Sci, Ctr Excellence Sickle Cell Dis Res & Training, Abuja, Nigeria
[8] Lebanese Amer Univ, Gilbert & Rose Marie Chagoury Sch Med, Byblos & NINI Hosp, Tripoli, Lebanon
[9] Childrens Hosp Michigan, Div Hematol Oncol, Detroit, MI USA
[10] Univ Estadual Campinas, Hematol & Transfus Med Ctr, Hemoctr, Campinas, SP, Brazil
[11] Univ Campinas Unicamp, Campinas, Brazil
[12] Mondor Univ Hosp, Reference Ctr Sickle Cell Dis, Creteil, France
[13] Univ Padua, Pediat Hematol Oncol Unit, Padua, Italy
[14] Amer Univ Beirut, Med Ctr, Beirut, Lebanon
[15] Amer Univ, Dept Pediat & Adolescent Med, Beirut Med Ctr, Beirut, Lebanon
[16] Agios Pharmaceut Inc, Cambridge, MA USA
[17] ITeos Therapeut, Watertown, MA USA
[18] Agios Pharmaceut Inc, Time Res, Cambridge, MA USA
[19] Virginia Commonwealth Univ, Richmond, VA USA
关键词
D O I
10.1182/blood-2023-187033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Results from PIONEER: a randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent systemic mastocytosis
    Radia, Deepti H.
    Sabato, Vito
    Castells, Mariana
    Akin, Cem
    Elberink, Hanneke Oude
    Tashi, Tsewang
    George, Tracy I.
    Roche, Maria
    DeAngelo, Daniel J.
    Gotlib, Jason
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 8 - 9
  • [22] Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study
    Stephen A. Harrison
    Federico Perez Manghi
    William B. Smith
    Diana Alpenidze
    Diego Aizenberg
    Naomi Klarenbeek
    Chi-Yi Chen
    Eli Zuckerman
    Eric Ravussin
    Phunchai Charatcharoenwitthaya
    Pin-Nan Cheng
    Helena Katchman
    Samuel Klein
    Ziv Ben-Ari
    Anisha E. Mendonza
    Yiming Zhang
    Miljen Martic
    Shenglin Ma
    Sheena Kao
    Sandra Tanner
    Alok Pachori
    Michael K. Badman
    YanLing He
    Chinweike Ukomadu
    Eric Sicard
    Nature Medicine, 2022, 28 : 1432 - 1438
  • [23] Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study
    Harrison, Stephen A.
    Manghi, Federico Perez
    Smith, William B.
    Alpenidze, Diana
    Aizenberg, Diego
    Klarenbeek, Naomi
    Chen, Chi-Yi
    Zuckerman, Eli
    Ravussin, Eric
    Charatcharoenwitthaya, Phunchai
    Cheng, Pin-Nan
    Katchman, Helena
    Klein, Samuel
    Ben-Ari, Ziv
    Mendonza, Anisha E.
    Zhang, Yiming
    Martic, Miljen
    Ma, Shenglin
    Kao, Sheena
    Tanner, Sandra
    Pachori, Alok
    Badman, Michael K.
    He, YanLing
    Ukomadu, Chinweike
    Sicard, Eric
    NATURE MEDICINE, 2022, 28 (07) : 1432 - +
  • [24] APREMILAST FOR ACTIVE ULCERATIVE COLITIS: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Danese, Silvio
    Neurath, Markus
    Kopon, Adam
    Zakko, Salam F.
    Simmons, Timothy C.
    Fogel, Ronald P.
    Maccarone, Judy
    Zhan, Xiaojiang
    Usiskin, Keith
    Chitkara, Denesh
    GASTROENTEROLOGY, 2018, 154 (06) : S167 - S167
  • [25] Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
    Gupta, Pawan Kumar
    Maheshwari, Sunil
    Cherian, Joe Joseph
    Goni, Vijay
    Sharma, Arun Kumar
    Tripathy, Sujith Kumar
    Talari, Keerthi
    Pandey, Vivek
    Sancheti, Parag Kantilal
    Singh, Saurabh
    Verma, Nikhil N.
    Kumar, Uday
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2023, 51 (09): : 2254 - 2266
  • [26] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY OF SUBCUTANEOUS BATOCLIMAB IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
    Nowak, Richard J.
    Benatar, Michael
    Breiner, Ari
    Isaacman, Daniel J.
    Bril, Vera
    MUSCLE & NERVE, 2022, 65 : S21 - S21
  • [27] A randomized double-blind placebo-controlled phase 2 study on the efficacy and safety of fasudil in patients with stable angina
    Vicari, RM
    Chaitman, B
    Keefe, D
    Smith, WB
    Chrysant, ST
    Tonkon, MJ
    Bittar, N
    Weiss, RJ
    Thadani, U
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 254A - 254A
  • [28] A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease
    Targan, Stephan R.
    Feagan, Brian
    Vermeire, Severine
    Panaccione, Remo
    Melmed, Gil Y.
    Landers, Carol
    Li, Dalin
    Russell, Chris
    Newmark, Richard
    Zhang, Nan
    Chon, Yun
    Hsu, Yi-Hsiang
    Lin, Shao-Lee
    Klekotka, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (11): : 1599 - 1607
  • [29] Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Pergola, Pablo E.
    Devalaraja, Matt
    Fishbane, Steven
    Chonchol, Michel
    Mathur, Vandana S.
    Smith, Mark T.
    Lo, Larry
    Herzog, Kurt
    Kakkar, Rahul
    Davidson, Michael H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (01): : 211 - 222
  • [30] A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Talactoferrin in Patients With Severe Sepsis
    Guntupalli, Kalpalatha
    Dean, Nathan
    Morris, Peter E.
    Bandi, Venkata
    Margolis, Benjamin
    Rivers, Emanuel
    Levy, Mitchell
    Lodato, Robert F.
    Ismail, Preeti M.
    Reese, Amber
    Schaumberg, John P.
    Malik, Rajesh
    Dellinger, R. Phillip
    CRITICAL CARE MEDICINE, 2013, 41 (03) : 706 - 716